How Ben Sasse Is Living Now That He Is Dying | Interesting Times with Ross Douthat

| Podcasts | April 09, 2026 | 25 Thousand views | 1:06:16

TL;DR

Former Senator Ben Sasse discusses his Stage 4 pancreatic cancer diagnosis with Ross Douthat, explaining why he is spending his final months doing interviews rather than bucket-list travel, and how targeted therapy has shrunk his tumors by 76% while he faces the reality that the cancer remains terminal.

⚕️ The Diagnosis & Medical Reality 3 insights

Rapid onset of terminal cancer

Sasse went from training for triathlons in October to receiving a Stage 4 pancreatic cancer diagnosis in December, with tumors already metastasized to his lymph nodes, vascular system, lungs, and liver—five distinct cancers total.

"Torso is chock-full of tumors"

Doctors delivered the news immediately after a full-body scan, informing him the cancer was inoperable and post-surgical, with an initial life expectancy of just three to four months.

Why remission is impossible despite tumor shrinkage

While Sasse's tumors have shrunk 76% since December 29th, oncologists explained that the cancer has already "seeded" his body; like dandelions spreading from neighboring yards, new tumors will inevitably emerge elsewhere.

💊 Treatment & Daily Survival 3 insights

Targeted therapy vs. carpet-bombing chemo

Instead of traditional chemotherapy, Sasse enrolled in a clinical trial at M.D. Anderson Houston taking an oral drug called daraxonrasib from Revolution Medicine, requiring him to be in Houston only two days per week.

Managing the four variables of end-of-life care

His hospice doctor outlined the algorithm of terminal abdominal cancer: managing tumor-driven pain, treatment-driven nausea, the diarrhea-to-constipation continuum, and energy levels—where treating one variable typically disrupts the other three.

Visible physical toll with humor

The drug prevents his body from growing skin properly, causing his face to bleed and burn; a pharmacist recently asked if he had received "electrical" shocks or acid burns, prompting Sasse to joke about fighting six different mafias.

🎙️ Confronting Mortality Publicly 3 insights

Dying in public to "redeem the time"

Rather than traveling or retreating privately, Sasse chose to do interviews and launch a podcast because he has limited time to give "unsolicited advice" to his children and wants to share his perspective on facing death.

Theological clarity and family focus

The diagnosis has sharpened his focus on his wife Melissa, their three children (ages 24, 22, and 14), and his faith, believing that "death doesn't get the final word" even as he accepts his prognosis.

Realistic about the outcome

Sasse acknowledges no one survives Stage 4 pancreatic cancer, and while his oncologists compare their work to chipping away at a Hoover Dam with pickaxes, he understands the dam will eventually break.

Bottom Line

When facing finite time, clarity comes from focusing on immediate relationships and faith rather than achievements or travel, choosing to be present with family while accepting mortality with both humor and hope.

More from Interesting Times with Ross Douthat

View all
How Far Will Trump Go in Iran? | Interesting Times with Ross Douthat
48:52
Interesting Times with Ross Douthat Interesting Times with Ross Douthat

How Far Will Trump Go in Iran? | Interesting Times with Ross Douthat

Mark Dubowitz, CEO of the Foundation for Defense of Democracies, argues the US is decisively winning its three-week military campaign against Iran by degrading missile, naval and nuclear capabilities, but warns that the closure of the Strait of Hormuz represents an inevitable confrontation that must be resolved now—while Iran is weakened—rather than postponed to a future where a cash-rich, nuclear-armed Iran could dominate the Gulf.

14 days ago · 9 points
White Identity Is Galvanizing the Right  | Interesting Times with Ross Douthat
1:02:51
Interesting Times with Ross Douthat Interesting Times with Ross Douthat

White Identity Is Galvanizing the Right | Interesting Times with Ross Douthat

Claremont Institute senior fellow Jeremy Carl defends his State Department nomination and book "The Unprotected Class," arguing that disparate impact laws, mass immigration since 1965, and DEI initiatives have created systemic discrimination against white Americans—a condition he terms "cultural genocide"—while insisting he advocates civic nationalism rather than white nationalism.

22 days ago · 9 points
The Democrats Could Still Screw This Up | Interesting Times With Ross Douthat
1:05:04
Interesting Times with Ross Douthat Interesting Times with Ross Douthat

The Democrats Could Still Screw This Up | Interesting Times With Ross Douthat

Despite being 'crushed' in 2024 with only 28% favorability, Democrats are regaining confidence due to Trump's perceived overreach on constitutional authority and tariffs, though deep internal conflicts over tactics, generational leadership, and divisive policy battles threaten recovery without a clear affirmative vision for the country.

29 days ago · 8 points